Strand, V., Gossec, L., Proudfoot, C. W. J., Chen, C., Reaney, M., Guillonneau, S., . . . Burmester, G. R. (2018). Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. Arthritis Res Ther.
استشهاد بنمط شيكاغوStrand, Vibeke, et al. "Patient-reported Outcomes From a Randomized Phase III Trial of Sarilumab Monotherapy Versus Adalimumab Monotherapy in Patients With Rheumatoid Arthritis." Arthritis Res Ther 2018.
MLA استشهادStrand, Vibeke, et al. "Patient-reported Outcomes From a Randomized Phase III Trial of Sarilumab Monotherapy Versus Adalimumab Monotherapy in Patients With Rheumatoid Arthritis." Arthritis Res Ther 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.